1. The Japanese Breast Cancer Society Clinical Practice Guidelines for surgical treatment of breast cancer, 2022 edition

   • Takehiko Sakai
   • Goro Kutomi
   • Shigehira Saji

   Special Article 16 October 2023 Pages: 1 - 7

2. The Japanese breast cancer society clinical practice guidelines for pathological diagnosis of breast cancer, 2022 edition

   • Naoko Honma
   • Masayuki Yoshida
   • Shigehira Saji

   Special Article Open access 07 November 2023 Pages: 8 - 15

3. Annual report of the Japanese Breast Cancer Registry for 2019

   • Minoru Miyashita
   • Hiraku Kumamaru
   • Shigehira Saji

   Special Article 04 December 2023 Pages: 16 - 23

   

4. Rethinking screening mammography in Japan: next-generation breast cancer screening through breast awareness and supplemental ultrasonography

   • Takayoshi Uematsu

   Review Article Open access 12 October 2023 Pages: 24 - 30

   

5. Long-term prognostic value of the GenesWell BCT score in Asian women with hormone receptor-positive/HER2-negative early breast cancer

   • Yoshitaka Fujiki
   • Masahiro Kashiwaba
   • Yasuaki Sagara

   Original Article Open access 09 October 2023 Pages: 31 - 41

   

6. Psychometric evaluation of the Chinese version of the breast cancer perception scale for community women: a translation and validation study

   • Linghui Kong
   • Zhen Yang
   • Huijun Zhang

   Original Article 13 October 2023 Pages: 42 - 52

   

7. Overall survival in Japanese patients with ER+/HER2− advanced breast cancer treated with first-line palbociclib plus letrozole

   • Masato Takahashi
   • Tomofumi Osako
   • Norikazu Masuda

   Original Article Open access 26 October 2023 Pages: 53 - 62

   

8. A novel system to provide information via online YouTube videos and an evaluation of current online information about hereditary breast cancer

   • Asumi Iesato
   • Atsushi Fushimi
   • Nami Yamashita

   Original Article Open access 23 November 2023 Pages: 63 - 74

   

9. Feasibility of accelerated partial breast irradiation with strut-adjusted volume implant brachytherapy in Japan focusing on dosimetry and acute toxicity: a Japanese multi-institutional prospective study

   • Masahiro Yoshida
   • Ryo-ichi Yoshimura
   • Working group of APBI with SAVIs in Japan (WASAVIs)

   Original Article 21 October 2023 Pages: 75 - 83

   

10. Population-level impact of adjuvant trastuzumab emtansine on the incidence of metastatic breast cancer: an epidemiological prediction model of women with HER2-positive early breast cancer and residual disease following neoadjuvant therapy

    • Mellissa Williamson
    • David J. Press
    • Kaustubh Gururaj

    Original Article Open access 01 November 2023 Pages: 84 - 95

    

11. SLC38A5 promotes glutamine metabolism and inhibits cisplatin chemosensitivity in breast cancer

    • Xiaowei Shen
    • Ganggang Wang
    • Weixing Shen

    Original Article 02 November 2023 Pages: 96 - 104

    

12. Medical care costs according to the stage and subtype of breast cancer in a municipal setting: a case study of Hachioji City, Japan

    • Yoshitaka Nishikawa
    • Nobukazu Agatsuma
    • Takeo Nakayama

    Original Article Open access 20 November 2023 Pages: 105 - 115

    

13. Hepatitis C virus may accelerate breast cancer progression by increasing mutant p53 and c-Myc oncoproteins circulating levels

    • Amira Fathy
    • Mohamed A. Abdelrazek
    • Mohamed El-Far

    Original Article Open access 16 November 2023 Pages: 116 - 123

    

14. Fatigue and quality of life during neoadjuvant chemotherapy of early breast cancer: a prospective multicenter cohort study

    • Florian Pelzer
    • Wilfried Tröger
    • Daniela Paepke

    Original Article Open access 15 November 2023 Pages: 124 - 134

15. IDO-1 impairs antitumor immunity of natural killer cells in triple-negative breast cancer via up-regulation of HLA-G

    • Rui Jing
    • Shukun Bai
    • Guoxu Zheng

    Original Article Open access 19 November 2023 Pages: 135 - 147

    

16. Machine learning applied in patient-reported outcome research—exploring symptoms in adjuvant treatment of breast cancer

    • Helle Pappot
    • Benóný P. Björnsson
    • Cecilie Holländer-Mieritz

    Rapid Communication 08 November 2023 Pages: 148 - 153

    

17. Comment on ‘An increase in tumor-infiltrating lymphocytes after treatment is significantly associated with a poor response to neoadjuvant endocrine therapy for estrogen receptor-positive/HER2-negative breast cancers’ by Fukui et al.

    • Yoshiya Horimoto

    Letter to the Editor 20 November 2023 Pages: 154 - 154

18. Are breast cancer subtypes different in breast cancer patients with and without hepatitis C virus infection?

    • Kadri Altundag

    Letter to the Editor 09 December 2023 Pages: 155 - 155